Viatris will spend as much as $335 million to settle opioid-related claims against the Canonsburg-based pharmaceutical company.
The proposed settlement over nine years would come in the form of nine annual payments of between $27.5 million and $40 million to states and local governments that would support opioid-related treatment and other efforts.
“While the company’s presence in the U.S. opioids market is very small, the company has agreed to this settlement to provide closure on these matters,” Viatris (Nasdaq: VTRS) said in a statement released Monday. “This settlement is in no way an admission of wrongdoing or liability.”
Viatris becomes the latest pharmaceutical company to reach a settlement with states, local governments and others over the opioid crisis. There have been about $50 billion in settlements over the past several years, with the most recent being the $7.4 billion announced in January by Purdue Pharma and its owners, the Sackler family. In the Purdue Pharma/Sackler settlement, Pennsylvania will receive $212 million.
Click here to read more from our partners at the Pittsburgh Business Times.
Download the FREE WPXI News app for breaking news alerts.
Follow Channel 11 News on Facebook and Twitter. | Watch WPXI NOW
©2025 Cox Media Group
